The role of the retina in neurological diseases and new concepts in ocular surface disease will headline special symposia at the American Academy of Optometry’s annual conference. Medscape Medical News
Author: Medscape
An Adult With Unilateral Mydriasis
A 34-year-old man was noted to have mydriasis of the right eye. What is the most likely diagnosis? Medscape Ophthalmology
FDA: Blindness Risk From Compounded Vancomycin Eye Injections
The FDA is warning against intraocular injections of vancomycin either alone or in combination with other drugs, in light of a new case of hemorrhagic occlusive retinal vasculitis. News Alerts
Rapid Ascent to High Altitude Alters the Retina
Significant increases in retinal nerve fiber layer (RNFL) thickness occur after rapid ascent to a high-altitude environment and can lead to other pathological changes, researchers from China report. Reuters Health Information
‘Generic Equivalent’: What Does That Really Mean?
Generic? Authorized generic? Biosimilar? Here is one take on the myriad of drug types now available. Medscape Optometry
Eyedrops for Diabetic Retinopathy Possible in the Future?
Contrary to hypothesis, neurodysfunction preceded microvascular impairment in only a minority of diabetic-retinopathy patients, but in that subgroup, neuroprotective eyedrops arrested disease progression. Medscape Medical News
Low LDL Target, No Clinical Gain in Non-CAD Diabetes: EMPATHY
Statins aimed at reducing LDL-C to less than 70 mg/dL didn’t cut cardiovascular events, but an intriguing post hoc finding suggests there may yet be benefit, in this trial of patients with diabetic retinopathy. Medscape Medical News
Bariatric Surgery May Reduce Retinopathy Risk, Progression
Roux-en-Y gastric bypass reduced diabetic retinopathy risk regardless of postsurgery diabetes status in a two-phase trial; a second study confirms obesity-related microvascular changes are reversible. Medscape Medical News
Key Micronutrients and Food Groups in Late-Stage AMD
How does nutritional intake differ between healthy patients and those with late-stage age-related macular degeneration? The British Journal of Ophthalmology
J-DOIT3: ‘Aim for Near-Normal Metabolic Parameters’ in Diabetes
UPDATED // The large Japanese DOIT3 trial tells clinicians that optimal lipid, blood pressure, and, glycemic control are important to reduce microvascular and macrovascular complications in type 2 diabetes. Medscape Medical News
Avoiding Malpractice in Refractive Surgery
Dr Christopher Rapuano looks at new data on how an avoidable error may be costing ophthalmologists millions. Medscape Ophthalmology
Antibiotics for Viral Conjunctivitis: It’s Still Happening
According to a new study, prescription of antibiotics for viral conjunctivitis continues to be a widespread practice. ‘Sobering’ and ‘discouraging,’ says an optometrist. Medscape Optometry
Nerf Guns ‘Can Cause Serious Eye Injuries’
Doctors are warning that a toy gun popular with children can cause serious eye injuries. WebMD Health News
Artificial Intelligence May Transform Retinal Screening
The new technology is a potential breakthrough for diabetic retinopathy screening, but is not without risks. Medscape Ophthalmology
AMD: Brolucizumab Noninferior to Aflibercept in Early Study
A small phase 2 study suggests that brolucizumab is as safe and effective as aflibercept for treating patients with age-related macular degeneration. Medscape Medical News
Breakthrough Treatments Arriving for Uveal Melanoma
Gene testing and immunotherapy have opened the door to treatments that could save the eyesight and the lives of people with uveal melanoma. Medscape Medical News
Life- and Eye-Saving New Treatments for Uveal Melanoma
Gene testing and immunotherapy have opened the door to treatments that could save the eyesight and the lives of people with uveal melanoma. Medscape Medical News
OCT Screening Cost-effective for Diabetic Retinopathy
It might make sense to screen everyone with diabetes for retinopathy using optical coherence tomography (OCT), new research suggests. Medscape Medical News
Ranibizumab Beats Laser for Diabetic Retinopathy
New trial findings are challenging the standard of care for diabetic retinopathy and are opening the door to wider use of anti-vascular endothelial growth factor drugs. Medscape Medical News
Analysis Favors Aflibercept for Diabetic Macular Edema
Aflibercept appears to be more effective than ranibizumab, with or without laser photocoagulation, in a new meta-analysis of treatments for diabetic macular edema. Medscape Medical News